Vice President & General Manager, U.S. Orthopedics · CONMED Corp (CNMD)

Nathan Folkert

A named executive officer of CONMED in every fiscal year CompBrief holds from FY2016 to FY2019. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$1,288,742

Salary $371,500Stock awards $0Bonus $25,000

FY2018: $1,152,081

5th of 5 named executive officers at Conmed by FY2019 total.

5 named officers on file for CONMED, FY2019

Nathan Folkert’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 2 equity grants, each cited to its filing
  • CNMD’s disclosed peer group of 13 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how CONMED’s whole pay program stands against its peers

  • CONMED’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CNMD→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 10, 2020 (DEF 14A).

Free

Get Nathan Folkert’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Nathan Folkert compensation by year

CONMED Summary Compensation Table · all 4 fiscal years held
In US dollars, as CONMED reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019
Salary$352,827$356,446$362,839$371,500
Bonus$0$0$0$25,000
Stock awards$79,740$67,088$0$0
Option awards$330,220$362,520$523,600$661,760
Non-equity incentive$128,568$111,181$241,514$202,278
Pension and deferred compensation$0$0$0$0
All other$115,646$22,368$24,128$28,204
Total$1,007,001$919,603$1,152,081$1,288,742

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CONMED Corp DEF 14A filed April 10, 2020, accession 0000816956-20-000007, and prior-year filings. Open the filing on EDGAR.

How this page was built: the CONMED Corp filed document, accession 0000816956-20-000007. Every figure is read from that document and cited to the page and table it appears in. Filed April 10, 2020.

$1.0M
$920K
$1.2M
$1.3M
FY16
FY17
FY18
FY19
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2019 year-end
TypeUnvested unitsValue at year-endExercise price
RSU800$89,464—
RSU500$55,915—
Option32,000—$78.76
Option15,200—$39.87
Option21,600—$41.93
Option28,000—$59.96

Per the Outstanding Equity Awards at Fiscal Year-End table in CONMED Corp's FY2019 proxy; value at the fiscal year-end close, as the company printed it.

CONMED’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
Curt HartmanPresident & Chief Executive Officer$6,180,260
Todd GarnerExecutive Vice President and Chief Financial Officer$2,437,745
Patrick BeyerPresident, CONMED International$2,085,421
Stanley PetersVice President & General Manager, U.S. Advanced Surgical$1,520,424
Nathan Folkert · this pageVice President & General Manager, U.S. Orthopedics$1,288,742

The full CONMED compensation record

free company brief

This page is one person within CONMED's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the CONMED proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are CONMED's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Nathan Folkert's compensation dossier · One-time report. No refunds.